The cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via induction of apoptosis and cell cycle arrest in G2/M stage
Tóm tắt
Bladder cancer is the second common malignancy of genitourinary tract, and transitional cell carcinomas (TCCs) account for 90% of all bladder cancers. Due to acquired resistance of TCC cells to a wide range of chemotherapeutic agents, there is always a need for search on new compounds for treatment of these cancers. Coumarins represent a group of natural compounds, which some of them have exerted valuable anti-tumor activities. The current study was designed to evaluate anti-tumor properties and mechanism of action of 7-isopentenyloxycoumarin, a prenyloxycoumarin, on 5637 cells (a TCC cell line). MTT results revealed that the cytotoxic effects of 7-isopentenyloxycoumarin on 5637 cancerous cells were more prominent in comparison to HDF-1 normal cells. This coumarin increased the amount of chromatin condensation and DNA damage in 5637 cells by 58 and 33%, respectively. The results also indicated that it can induce apoptosis most probably via activation of caspase-3 in these cells. Moreover, propidium iodide staining revealed that 7-isopentenyloxycoumarin induced cell cycle arrest at G2/M stage, after 24 h of treatment. Our results indicated that 7-isopentenyloxycoumarin had selective toxic effects on this bladder cancer cell line and promoted its effects by apoptosis induction and cell cycle arrest. This coumarin can be considered for further studies to reveal its exact mechanism of action and also its anti-cancer effects in vivo.
Tài liệu tham khảo
Coseri S: Natural products and their analogues as efficient anticancer drugs. Mini Rev Med Chem. 2009, 9: 560-571. 10.2174/138955709788167592.
Bolenz C, Becker A, Trojan L, Schaaf A, Cao Y, Weiss C, Alken P, Michel MS: Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides. Urol Oncol. 2007, 25: 476-482. 10.1016/j.urolonc.2007.01.017.
Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM, Theodorescu D: Profiling the evolution of human metastatic bladder cancer. Cancer Res. 2004, 64: 7813-7821. 10.1158/0008-5472.CAN-04-0826.
Behnam Rassouli F, Matin MM, Iranshahi M, Bahrami AR, Neshati V, Mollazadeh S, Neshati Z: Mogoltacin enhances vincristine cytotoxicity in human transitional cell carcinoma (TCC) cell line. Phytomedicine. 2009, 16: 181-187. 10.1016/j.phymed.2008.06.011.
Kannan K, Jain SK: Oxidative stress and apoptosis. Pathophysiology. 2000, 7: 153-163. 10.1016/S0928-4680(00)00053-5.
Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16: 3-11. 10.1038/cdd.2008.150.
Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007, 35: 495-516. 10.1080/01926230701320337.
Curini M, Cravotto G, Epifano F, Giannone G: Chemistry and biological activity of natural and synthetic prenyloxycoumarins. Curr Med Chem. 2006, 13: 199-222. 10.2174/092986706775197890.
Barthomeuf C, Lim S, Iranshahi M, Chollet P: Umbelliprenin from Ferula szowitsiana inhibits the growth of human M4Beu metastatic pigmented malignant melanoma cells through cell-cycle arrest in G1 and induction of caspase-dependent apoptosis. Phytomedicine. 2008, 15: 103-111. 10.1016/j.phymed.2007.04.001.
Chuang JY, Huang YF, Lu HF, Ho HC, Yang JS, Li TM, Chang NW, Chung JG: Coumarin induces cell cycle arrest and apoptosis in human cervical cancer HeLa cells through a mitochondria- and caspase-3 dependent mechanism and NF-kappaB down-regulation. In Vivo. 2007, 21: 1003-1009.
Lopez-Gonzalez JS, Prado-Garcia H, Aguilar-Cazares D, Molina-Guarneros JA, Morales-Fuentes J, Mandoki JJ: Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer. 2004, 43: 275-283. 10.1016/j.lungcan.2003.09.005.
Riveiro ME, De Kimpe N, Moglioni A, Vazquez R, Monczor F, Shayo C, Davio C: Coumarins: old compounds with novel promising therapeutic perspectives. Curr Med Chem. 2010, 17: 1325-1338. 10.2174/092986710790936284.
Askari M, Sahebkar A, Iranshahi M: Synthesis and purification of 7-prenyloxycoumarins and herniarin as bioactive natural coumarins. Iranian J Basic Med Sci. 2009, 12: 63-69.
Epifano F, Pelucchini C, Curini M, Genovese S: Insights on novel biologically active natural products: 7-isopentenyloxycoumarin. Nat Prod Commun. 2009, 4: 1755-1760.
Baba M, Jin Y, Mizuno A, Suzuki H, Okada Y, Takasuka N, Tokuda H, Nishino H, Okuyama T: Studies on cancer chemoprevention by traditional folk medicines XXIV. Inhibitory effect of a coumarin derivative, 7-isopentenyloxycoumarin, against tumor-promotion. Biol Pharm Bull. 2002, 25: 244-246. 10.1248/bpb.25.244.
Epifano F, Molinaro G, Genovese S, Ngomba RT, Nicoletti F, Curini M: Neuroprotective effect of prenyloxycoumarins from edible vegetables. Neurosci Lett. 2008, 443: 57-60. 10.1016/j.neulet.2008.07.062.
Rezaee R, Hashemzaie M, Iranshahi M, Behravan E, Behravan J, Soltani F: Evaluation of antigenotoxic effect of 7-hydroxy coumarin and 7-isopentenyloxy coumarin on human peripheral lymphocytes exposed to oxidative stress. Toxicol Lett. 2011, 205: 108-
Epifano F, Curini M, Menghini L, Genovese S: Natural coumarins as a novel class of neuroprotective agents. Mini Rev Med Chem. 2009, 9: 1262-1271. 10.2174/138955709789878141.
van Meerloo J, Kaspers GJ, Cloos J: Cell sensitivity assays: the MTT assay. Methods Mol Biol. 2011, 731: 237-245. 10.1007/978-1-61779-080-5_20.
Collins AR: The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol. 2004, 26: 249-261. 10.1385/MB:26:3:249.
Epifano F, Genovese S, Menghini L, Curini M: Chemistry and pharmacology of oxyprenylated secondary plant metabolites. Phytochemistry. 2007, 68: 939-953. 10.1016/j.phytochem.2007.01.019.
Rassouli FB, Matin MM, Iranshahi M, Bahrami AR: Investigating the cytotoxic and apoptosis inducing effects of monoterpenoid stylosin in vitro. Fitoterapia. 2011, 82: 742-749. 10.1016/j.fitote.2011.03.005.
Bruyere C, Genovese S, Lallemand B, Ionescu-Motatu A, Curini M, Kiss R, Epifano F: Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines. Bioorg Med Chem Lett. 2011, 21: 4174-4179. 10.1016/j.bmcl.2011.05.089.
Kawaii S, Tomono Y, Ogawa K, Sugiura M, Yano M, Yoshizawa Y, Ito C, Furukawa H: Antiproliferative effect of isopentenylated coumarins on several cancer cell lines. Anticancer Res. 2001, 21: 1905-1911.
Kofinas C, Chinou I, Loukis A, Harvala C, Roussakis C, Maillard M, Hostettmann K: Cytotoxic coumarins from the aerial parts of Tordylium apulum and their effects on a non-small-cell bronchial carcinoma line. Planta Med. 1998, 64: 174-176. 10.1055/s-2006-957398.
Gottesman MM: How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 1993, 53: 747-754.
Shoemaker RH, Curt GA, Carney DN: Evidence for multidrug-resistant cells in human tumor cell populations. Cancer Treat Rep. 1983, 67: 883-888.
Choi CH: ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int. 2005, 5: 30-35. 10.1186/1475-2867-5-30.
Wu C, Zhang W, Chang J, Zhao Z, Sun G, Han R: MDR1/P-glycoprotein overexpression in bladder transitional cell carcinoma and its correlation with expression of survivin and Fas. Chin J Onco. 2006, 3: 191-195. 10.1007/s11805-006-0117-x.
Hasegawa M, Yagi K, Iwakawa S, Hirai M: Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells. Jpn J Cancer Res. 2001, 92: 459-466. 10.1111/j.1349-7006.2001.tb01116.x.
Nguyen SM, Lieven CJ, Levin LA: Simultaneous labeling of projecting neurons and apoptotic state. J Neurosci Methods. 2007, 161: 281-284. 10.1016/j.jneumeth.2006.10.026.
Das GC, Holiday D, Gallardo R, Haas C: Taxol-induced cell cycle arrest and apoptosis: dose–response relationship in lung cancer cells of different wild-type p53 status and under isogenic condition. Cancer Lett. 2001, 165: 147-153. 10.1016/S0304-3835(01)00404-9.
Ling YH, el-Naggar AK, Priebe W, Perez-Soler R: Cell cycle-dependent cytotoxicity, G2/M phase arrest, and distruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized p388 cells. Mol Pharmacol. 2012, 81: 832-841. 10.1124/mol.111.077446.
Blajeski AL, Phan VA, Kottke TJ, Kaufmann SH: G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells. J Clin Invest. 2002, 110: 91-99.
Dash BC, El-Deiry WS: Phosphorylation of p21 in G/M promotes cyclin B -Cdc2 kinase activity. Mol Cell Biol. 2005, 25: 3364-3387. 10.1128/MCB.25.8.3364-3387.2005.
Abdollahi M, Shetab-Boushehri SV: Is it right to look for anti-cancer drugs amongst compounds having antioxidant effect?. DARU. 2012, 20: 61-10.1186/2008-2231-20-61.
Shetab-Boushehri SV, Abdollahi M: Current concerns on the validity of in vitro models that use transformed neoplastic cells in pharmacology and toxicology. Int J Pharmacol. 2012, 8: 594-595. 10.3923/ijp.2012.594.595.